Evaluation of the Clinitek®, a point-of-care urinalysis system for the measurement of clinically significant urinary metabolites and detection of haematuria in Schistosoma haematobium infected children in southern Cote d'IvoirePARASITES & VECTORSIF3.52019-06-131OAAI
Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trialBMC MEDICINEIF8.32018-06-0116OAAI
Evaluation of a novel micro-sampling device, Mitra™, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium-infected children in rural Cote d'IvoireJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12018-03-0123PREAI
In vitro and in vivo activity of R- and S-praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobiumPARASITES & VECTORSIF3.52017-08-0148OAAI
Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trialLANCET GLOBAL HEALTHIF182017-07-0157OAAI
Pharmacokinetic Study of Praziquantel Enantiomers and Its Main Metabolite R-trans-4-OH-PZQ in Plasma, Blood and Dried Blood Spots in Opisthorchis viverrini-Infected PatientsPLOS NEGLECTED TROPICAL DISEASESIF3.42016-05-0619OAAI
Development and validation of an enantioselective LC-MS/MS method for the analysis of the anthelmintic drug praziquantel and its main metabolite in human plasma, blood and dried blood spotsJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12016-01-0127PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向